NMRA Stock Summary and Trading Ideas (Neumora Therapeutics | NASDAQ:NMRA)

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

What symbol and exchange does Neumora Therapeutics shares trade?

Neumora Therapeutics trades on the NASDAQ stock market under the symbol NMRA.

What is Neumora Therapeutics stock price doing today?

As of January 8, 2026, NMRA stock price climbed to $2.33 with 2,821,759 million shares trading.

What is Neumora Therapeutics's Beta?

NMRA has a beta of 3.12, meaning it tends to be more sensitive to market movements. NMRA has a correlation of 0.07 to the broad based SPY ETF.

How much is Neumora Therapeutics worth?

NMRA has a market cap of $395.96 million. This is considered a Small Cap stock.

What are the top ETFs holding Neumora Therapeutics?

The top ETF exchange traded funds that NMRA belongs to (by Net Assets): VTI, VXF, SCHA, IBB, PRFZ.

Is Neumora Therapeutics (NMRA) a good investment?

NMRA has underperformed the market in the last year with a return of -9.7%, while SPY returned +18.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NMRA shares. However, NMRA has outperformed the market in the last 3 month and 2 week periods, returning +25.3% and +28.7%, while SPY returned +3.3% and -0.1%, respectively. This indicates NMRA has been having a stronger performance recently.

What are the support and resistance levels for Neumora Therapeutics (NMRA)?

NMRA support price is $2.13 and resistance is $2.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NMRA shares will trade within this expected range on the day.